ArticleEndocrinology2024

Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.

Timothy N Dunn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.